Stroke Trial, Recruiting (NCT06200753)

Stroke Trial, Recruiting NCT06200753 Sponsor: Tianjin Huanhu Hospital Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT06200753 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who were admitted to hospital between January 1, 2018 and January 1, 2028
People who arrived at the hospital more than 24 hours after the last time they were known to be well
People whose ischemic stroke (a stroke caused by a blocked blood vessel) was confirmed by a CT scan or MRI of the head
People who had a blockage in one of the major blood vessels in the brain, confirmed by a specialised scan of the blood vessels (such as a CT angiogram or MRI angiogram) — the blocked vessel must be one of several specific arteries in the brain (confirm with trial site for exact vessel details)
People who received either a procedure to physically remove or unblock the blood clot, or standard medical treatment for their stroke

Who may not be able to join:

People who had any type of bleeding in or around the brain, as shown on a CT or MRI scan taken when they were admitted to hospital

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06200753

Sponsor: Tianjin Huanhu Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

More information: https://clinicaltrials.gov/study/NCT06200753

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who were admitted to hospital between January 1, 2018 and January 1, 2028
People who arrived at the hospital more than 24 hours after the last time they were known to be well
People whose ischemic stroke (a stroke caused by a blocked blood vessel) was confirmed by a CT scan or MRI of the head
People who had a blockage in one of the major blood vessels in the brain, confirmed by a specialised scan of the blood vessels (such as a CT angiogram or MRI angiogram) — the blocked vessel must be one of several specific arteries in the brain (confirm with trial site for exact vessel details)
People who received either a procedure to physically remove or unblock the blood clot, or standard medical treatment for their stroke

Who may not be able to join:

People who had any type of bleeding in or around the brain, as shown on a CT or MRI scan taken when they were admitted to hospital

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Tianjin Huanhu Hospital

Registry

ClinicalTrials.gov

Start date

1 January 2018

Est. completion

31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Modified ranking scale (mRS) at 90 days; symptomatic intracranial hemorrhage

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov